Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Enanta Pharmaceuticals, Inc.”

218 pharma patents match "Enanta Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 218
Index total 30,257
Page 2 / 10

Quick answer

This filtered view shows 218 pharmaceutical patents matching "Enanta Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

218 results for “Enanta Pharmaceuticals, Inc.” · 30,257 patents in full index Clear search

  1. US 11718641

    Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Aug 8, 2023 · Expires Aug 3, 2043

    granted

  2. US 11596611

    Hepatitis B antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted

  3. US 11572367

    Antiviral heterocyclic compounds

    Enanta Pharmaceuticals, Inc. · Granted Feb 7, 2023 · Expires Feb 2, 2043

    granted

  4. US 11560368

    Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Jan 24, 2023 · Expires Jan 19, 2043

    granted

  5. US 11534439

    Dihydroquinoxaline and dihydropyridopyrazine derivatives as RSV inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted

  6. US 11472808

    Substituted pyrrolo[1,2-c]pyrimidines as hepatitis B antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted

  7. US 11420976

    Heterocyclic compounds as anti-viral agents

    Enanta Pharmaceuticals, Inc. · Granted Aug 23, 2022 · Expires Aug 18, 2042

    granted

  8. US 11390631

    Benzodiazepine derivatives as RSV inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jul 19, 2022 · Expires Jul 14, 2042

    granted

  9. US 11377450

    Functionalized heterocycles as antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Jul 5, 2022 · Expires Jun 30, 2042

    granted

  10. US 11358953

    Functionalized peptides as antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted

  11. US 11352363

    Spiropyrrolidine derived antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted

  12. US 11339170

    Spiropyrrolidine derived antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted May 24, 2022 · Expires May 19, 2042

    granted

  13. US 11325916

    Spiropyrrolidine derived antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted May 10, 2022 · Expires May 5, 2042

    granted

  14. US 11254664

    Benzodiazepine derivatives as RSV inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted

  15. US 11236111

    Hepatitis B antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted

  16. US 11198693

    Functionalized heterocycles as antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted

  17. US 11179400

    Heterocyclic compounds as RSV inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted

  18. US 11091501

    Heterocyclic compounds as RSV inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Aug 17, 2021 · Expires Aug 12, 2041

    granted

  19. US 11058678

    Substituted heterocycles as antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Jul 13, 2021 · Expires Jul 8, 2041

    granted

  20. US 11040998

    Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted

  21. US 11034684

    Isoxazole analogs as FXR agonists and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted

  22. US 11008304

    Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted May 18, 2021 · Expires May 13, 2041

    granted

  23. US 10988458

    Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted

  24. US 10975094

    Heterocyclic compounds as RSV inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Apr 13, 2021 · Expires Apr 8, 2041

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.